Golden handcuffs are the unvested equity, deferred compensation and retention awards that make leaving a company expensive. For pharma and biotech executives, they rarely arrive all at once. They build award by award over years of good performance, until staying is no longer fully voluntary. A useful check is to ask whether you would still choose to stay if none of this compensation were at risk.

Recent economic concerns have caused consumer sentiment to fall, though spending remains healthy. What do these mixed conditions mean for markets and the economy?

DOJI Know? The Ranks Try to Reassemble After last Friday’s S&P 500 doji on high upside Capital Weighted Volume, Monday opened the campaign with force as more than 75% of Capital Weighted Volume moved to the upside. Tuesday followed with the S&P 500 closing at a new all time high and reaching 7845 on a […]

Recent economic concerns have caused consumer sentiment to fall, though spending remains healthy. What do these mixed conditions mean for markets and the economy?